BridgePort Financial Solutions LLC Buys 116,927 Shares of Pfizer Inc. $PFE

BridgePort Financial Solutions LLC increased its stake in shares of Pfizer Inc. (NYSE:PFE) by 812.4% during the third quarter, HoldingsChannel.com reports. The firm owned 131,319 shares of the biopharmaceutical company’s stock after buying an additional 116,927 shares during the period. Pfizer accounts for 0.9% of BridgePort Financial Solutions LLC’s portfolio, making the stock its 29th largest position. BridgePort Financial Solutions LLC’s holdings in Pfizer were worth $3,346,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Curio Wealth LLC grew its position in shares of Pfizer by 36,600.0% during the 2nd quarter. Curio Wealth LLC now owns 1,101 shares of the biopharmaceutical company’s stock valued at $27,000 after purchasing an additional 1,098 shares in the last quarter. Grey Fox Wealth Advisors LLC bought a new stake in Pfizer during the third quarter valued at $29,000. Harbor Asset Planning Inc. purchased a new position in Pfizer during the second quarter worth about $29,000. Howard Hughes Medical Institute bought a new position in Pfizer in the 2nd quarter worth about $30,000. Finally, True Wealth Design LLC raised its holdings in shares of Pfizer by 302.5% in the 3rd quarter. True Wealth Design LLC now owns 1,296 shares of the biopharmaceutical company’s stock valued at $33,000 after acquiring an additional 974 shares in the last quarter. Hedge funds and other institutional investors own 68.36% of the company’s stock.

Analysts Set New Price Targets

PFE has been the topic of several research analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $27.00 price objective on shares of Pfizer in a research report on Wednesday, February 4th. Bank of America decreased their price target on shares of Pfizer from $29.00 to $28.00 and set a “neutral” rating on the stock in a report on Monday, December 15th. UBS Group initiated coverage on shares of Pfizer in a report on Tuesday, January 6th. They set a “neutral” rating and a $25.00 price objective for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Pfizer in a research note on Thursday, January 22nd. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $30.00 price target on shares of Pfizer in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $28.06.

Pfizer Stock Down 0.6%

Shares of NYSE:PFE opened at $27.05 on Tuesday. The stock has a market capitalization of $153.80 billion, a P/E ratio of 19.89 and a beta of 0.47. The stock’s 50-day moving average price is $25.65 and its 200-day moving average price is $25.11. The company has a current ratio of 1.28, a quick ratio of 0.97 and a debt-to-equity ratio of 0.62. Pfizer Inc. has a 12-month low of $20.92 and a 12-month high of $27.69.

Pfizer (NYSE:PFE) last released its earnings results on Tuesday, February 3rd. The biopharmaceutical company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.09. Pfizer had a return on equity of 20.25% and a net margin of 12.42%.The company had revenue of $17.56 billion during the quarter, compared to analyst estimates of $16.93 billion. During the same quarter in the previous year, the company posted $0.63 EPS. Pfizer’s revenue for the quarter was down 1.2% on a year-over-year basis. On average, equities analysts anticipate that Pfizer Inc. will post 2.95 earnings per share for the current year.

Pfizer Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, January 23rd will be issued a $0.43 dividend. The ex-dividend date is Friday, January 23rd. This represents a $1.72 annualized dividend and a dividend yield of 6.4%. Pfizer’s dividend payout ratio (DPR) is currently 126.47%.

Pfizer Company Profile

Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.

Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.